injectable ghk-cu dosage and Protocol: A Medical Provider's Guide to the 30-Day Cycle KLOW Dosing Guide: GHK-Cu +

Brun L, Aubin P, Soliman H, Villette JM, Berthon P, Cussenot O, et al

Patients in this study ranged from Type II to Type V

doi: 10.1002/ptr.1241

Researchers administered 15 mg/kg of GHK-Cu to aged (20-21 month) mice via two distinct paradigms: a short-term, 5-day intraperitoneal (IP) injection series, and a long-term, 8-week intranasal (IN) atomization protocol

The molecular integrity and high biological activity of the peptide are fully preserved at normal ambient temperatures throughout global transit

Clinicians, patients, and researchers need to balance possible advantages with safety data gaps, product inconsistencies, and drug interactions before using them